SERPINF1 and osteosarcoma: Ta et al. [256] formulated a chitosan hydrogel for pediatric osteosarcoma gene therapy using the pigment epithelium-derived factor (PEDF), with promising anti-tumor activity in vitro (SaOS-2 cells) and in vivo.